510(k) K211311
K211311 is an FDA 510(k) premarket notification submitted by AtriCure, Inc. for the device "AtriCure Isolator® Synergy Surgical Ablation System". The FDA issued a decision of Substantially Equivalent on May 28, 2021. The device falls under product code OCL (Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue), a Class II device regulated under 21 CFR 878.4400. AtriCure, Inc. has 59 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 28, 2021
- Date Received
- Apr 30, 2021
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue
- Device Class
- Class II
- Regulation Number
- 878.4400
- Review Panel
- CV
- Submission Type
- 510(k)
Surgical device for cutting, coagulation, and/or ablation of tissue, including cardiac tissue
Need the full FDA record for AtriCure, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.